Deletion analysis of the p16 tumour suppressor gene in phaeochromocytomas

Clinical Endocrinology

Volumn 45, Issue 1, 1996, Pages 93-96

  Aguiar, Ricardo C T ^a   Dahia, Patricia L M ^b   Sill, Heinz ^a   Toledo, Sergio P A ^c   Goldman, John M ^a   Cross, Nicholas C P ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE DELETION; HUMAN; HUMAN TISSUE; MALE; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; SCHOOL CHILD; TUMOR SUPPRESSOR GENE;

ADOLESCENT; ADRENAL GLAND NEOPLASMS; ADULT; CHILD; EXONS; GENE DELETION; GENES, TUMOR SUPPRESSOR; HUMANS; MIDDLE AGED; NEOPLASM PROTEINS; PHEOCHROMOCYTOMA; POLYMERASE CHAIN REACTION;

EID: 0029931446     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2265.1996.tb02065.x     Document Type: Article

References (19)

1. Bravo, E.L. & Gifford, R.W. (1984) Pheochromocytoma: diagnosis, localization and management. New England Journal of Medicine, 311, 1298-1303.
2. Dahia, P.L.M., Aguiar, R.C.T., Tsanaclis, A.M., Bendit, I., Bydlowski, S., Abelin, N.M.A. & Toledo, S.P.A. (1995) Molecular and immunohistochemical analysis of P53 in phaeochromocytomas. British Journal of Cancer, 72, 1211-1213.
3. Eng, C., Crossey, P.A., Mulligan, L.M., Healey, C.S., Houghton, C., Chew, S.L., Dahia, P.L.M., O'Riordan, J.L.H., Toledo, S.P.A., Smith, D.P., Maher, E.R. & Ponder, B.A.J. (1995) Mutations in the RET proto-oncogene and the von Hippel-Lindau disease tumour suppressor gene in sporadic and syndromic phaeochromocytomas. Journal of Medical Genetics, 32, 934-937.
4. Gutmann, D.H., Geist, R.T., Rose, K., Wallin, G. & Moley, J.F. (1995) Loss of neurofibromatosis type 1 (NF1) gene expression on pheochromocytomas from patients without NF1. Genes, Chromosomes and Cancer, 13, 104-109.
5. Herman, J.G., Merlo, A., Mao, L., Lapidus, R.G., Issa, J.P.J., Davidson, N.E., Sidransky, D. & Baylin, S.B. (1995) Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Research, 55, 4525-4530.
6. Hirama, T. & Koeffler, H.P. (1995) Review: Role of cyclin-dependent kinase inhibitors in the development of cancer. Blood, 86, 841-854.
7. Kamb, A., Gruis, N.A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S.V., Stockert, E., Day, R.S., Johnson, B.E. & Skolnick, M.H. (1994) A cell cycle regulator potentially involved in genesis of many tumour types. Science, 264, 436-440.
8. Khosla, S., Patel, V.M., Hay, I.D., Schaid, D.J., Grant, C.S., Van Heerden, J.A. & Thibodeau, S.N. (1991) Loss of heterozygosity suggests multiple genetic alterations in pheochromocytomas and medullary thyroid carcinomas. Journal of Clinical Investigation, 87, 1691-1699.
9. Latif, F., Tory, K., Gnarra, J., Yao, M., Duh, F.M., Orcutt, M.L., Stackhouse, T., Kuzmin, I., Modi, W., Geil, L., Schmidt, L., Zhou, F., Li, H., Wei, M.H., Chen, F., Glenn, G., Chayke, P., Walther, M.M. & Wang, Y. (1993) Identification of the von Hippel-Lindau disease tumour suppressor gene. Science, 260, 1317-1320.
10. Moley, J.F., Brother, M.B., Fong, C.-T., White, P.S., Baylin, S.B., Nelkin, B., Wells, S.A. & Brodeur, G.M. (1992) Consistent association of Ip loss of heterozygosity with pheochromocytomas from patients with multiple endocrine neoplasia type 2 syndromes. Cancer Research, 52, 770-774.
11. Mulligan, L.M., Eng, C., Healey, C.S., Clayton, D., Kwok, J.B.J., Gardner, E., Ponder, M.A., Frilling, A., Jackson, C.E., Lehnert, H., Neumann, H.P.H., Thibodeau, S.N. & Ponder, B.A.J. (1994) Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and F-MTC. Nature Genetics, 6, 70-74.
12. Peter, M. & Herskowitz, I. (1994) Joining the complex: cyclin-dependent kinase inhibitory proteins and the cell cycle. Cell, 79, 181-184.
13. Serrano, M., Hannon, G.J. & Beach, D. (1993) A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature, 366, 704-707.
14. Sherr, C.J. (1994) G1 phase progression: cyclin on cue. Cell, 79, 551-555.
15. Sill, H., Goldman, J.M. & Cross, N.C.P. (1995) Homozygous deletions of the p16 tumour-suppressor gene are associated with lymphoid transformation of chronic myeloid leukemia. Blood, 85, 2013-2016.
16. Tanaka, N., Nishisho, I., Yamamoto, M., Miya, A., Shin, E., Karakawa, K., Fujita, S., Kobayashi, T., Rouleau, G.A. Mori, T. & Takai, S. (1992) Loss of heterozygosity on the long arm of chromosome 22 in pheochromocytoma. Genes, Chromosomes and Cancer, 5, 399-403.
17. Tsutsumi, M., Yokota, J., Kakizoe, T., Koiso, K., Sugimura, T. & Terada, M. (1989) Loss of heterozygosity on the short arm of chromosomes 1p and 14p in sporadic pheochromocytoma. Journal of National Cancer Institute, 81, 367-370.
18. Viskochil, D., Buchberg, A.M., Xu, G., Cawthorn, A.M., Stevens, J., Wolff, R.K., Culver, M., Carey, J.C., Copeland, N.G., Jenkins, N.A., White, R. & O'Connell, P. (1990) Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus. Cell, 62, 187-192.
19. Zeiger, M.A., Zbar, B., Keiser, H., Linehan, W.M. & Gnarra, J.R. (1995) Loss of heterozygosity on the short arm of chromosome 3 in sporadic, von Hippel-Lindau disease-associated, and familial pheochromocytoma. Genes, Chromosomes and Cancer, 13, 151-156.